A detailed history of Klp Kapitalforvaltning As transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Klp Kapitalforvaltning As holds 6,700 shares of PRTA stock, worth $48,843. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,700
Previous 12,900 48.06%
Holding current value
$48,843
Previous $178,000 53.93%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 06, 2025

SELL
$12.38 - $16.04 $76,756 - $99,448
-6,200 Reduced 48.06%
6,700 $82,000
Q4 2024

Feb 11, 2025

BUY
$11.95 - $18.35 $154,155 - $236,715
12,900 New
12,900 $178,000

Others Institutions Holding PRTA

About PROTHENA CORP PUBLIC LTD CO


  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $342M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Klp Kapitalforvaltning As Portfolio

Follow Klp Kapitalforvaltning As and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Klp Kapitalforvaltning As, based on Form 13F filings with the SEC.

News

Stay updated on Klp Kapitalforvaltning As with notifications on news.